Neuro-oncology
Conference Coverage
New systemic therapies altering management of melanoma brain metastases
Approach to melanoma brain metastases shifts with advent of effective systemic therapy.
News
FDA investigating risk of gadolinium contrast agent brain deposits
Conference Coverage
ASCO: Precision medicine initiatives take wing
Conference Coverage
ASCO: Trial highlights cognitive toll of adjuvant whole-brain radiation
Key clinical point: Adding whole-brain radiation after radiosurgery increases the risk of cognitive decline in patients with limited brain...
News
Alzheimer’s drug improves cognitive function after RT for brain tumors
Key clinical point: Among adult brain tumor survivors who underwent partial- or whole-brain irradiation, treatment with donepezil compared with...
News
FDA approves first drug for high-risk neuroblastoma
Conference Coverage
‘Chemo brain’ may have targetable causes
Key clinical point: Cognitive decline following chemotherapy may be an interplay of aging and drug-induced molecular changes. Major finding: An...
Conference Coverage
Decompression can save lives in ventricular trapping
Key clinical point: Decompression for a trapped ventricle can be a life-saving procedure. Major finding: Mortality significantly declined from 70...
News
FDA looks to make companion diagnostics, lab tests more reliable
News
Bevacizumab fails to improve survival in newly diagnosed glioblastoma
Major finding: Two similar studies found no difference in median survival with the addition of bevacizumab to standard therapy for patients with...
Conference Coverage
New chemo regimen is active against recalcitrant neuroendocrine tumors
Major finding: The overall response rate was 43% and the clinical benefit rate was 97%. Data source: A randomized phase II trial among 28 patients...